Meigs's syndrome

From WikiMD's WELLNESSPEDIA

(Redirected from Meigs' syndrome)


Meigs's syndrome
Synonyms
Pronounce N/A
Specialty N/A
Symptoms Ascites, pleural effusion, ovarian tumor
Complications
Onset
Duration
Types
Causes Ovarian fibroma, thecoma, cystadenoma
Risks
Diagnosis Clinical evaluation, imaging studies
Differential diagnosis Pseudomeigs' syndrome, ovarian cancer, tuberculosis
Prevention
Treatment Surgical removal of the tumor
Medication
Prognosis Good with treatment
Frequency Rare
Deaths


Meigs's syndrome is a rare medical condition that involves a triad of ascites, pleural effusion, and benign ovarian tumor (fibroma, fibrothecoma, Brenner tumours, and occasionally granulosa cell tumours). The syndrome was named after Joe Vincent Meigs, an American obstetrician and gynecologist.

Symptoms[edit]

The symptoms of Meigs's syndrome include shortness of breath due to pleural effusion, abdominal swelling or distension due to ascites, and pelvic mass due to ovarian fibroma. Other symptoms may include weight loss, nausea, vomiting, and constipation.

Diagnosis[edit]

The diagnosis of Meigs's syndrome is typically made based on the presence of the triad of symptoms. Imaging studies such as ultrasound, CT scan, or MRI may be used to identify the presence of ascites, pleural effusion, and ovarian tumor. A biopsy of the ovarian tumor may be performed to confirm the diagnosis.

Treatment[edit]

The treatment for Meigs's syndrome typically involves surgical removal of the ovarian tumor. Following surgery, the ascites and pleural effusion usually resolve within a few weeks. In some cases, diuretics may be used to help reduce the ascites and pleural effusion.

Prognosis[edit]

The prognosis for Meigs's syndrome is generally good, as the ovarian tumors associated with this condition are usually benign. However, regular follow-up is necessary to monitor for potential recurrence of the tumor.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.